US federal judge tells FDA to lift age restrictions on morning-after pill

5 April 2013

A US federal judge has ordered the Food and Drug Administration to lift age and other restrictions on the sale of the morning-after pill, making the drug available to women of all ages over the counter.

The ruling by US District Court Judge Edward Korman reverses a 2011 decision by Health and Human Services Secretary Kathleen Sebelius not to allow the sale of emergency contraception without a prescription for women 16 and under.

According to a Bloomberg report, US District Judge Edward Korman in Brooklyn, New York, excoriated the Food and Drug Administration for what he called a 12-year delay in making the emergency contraceptive, known as Plan B and marketed by Israel-based Teva Pharmaceutical Industries (NYSE: TEVA) available over-the- counter. While acknowledging opponent contentions that increased access to contraception may encourage sexual conduct by minors, Judge Korman said the case is not about “the potential misuse of Plan B by 11-year-olds.”

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight





More Features in Pharmaceutical